Ahead of the Budget later this month, confidence among business chiefs in September was at its weakest since December 2022, ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out and floated in 2022.

Pfizer (NYSE:PFE) has reduced its ownership in the British consumer healthcare giant Haleon (NYSE:HLN) to 15% from 22.6% by ...

Exegenesis Bio’s SMA therapy is now in Phase 2 trials, building on earlier Phase 1 and 2 studies that demonstrated promising ...

Pfizer will receive around 2.66 billion pounds ($3.56 billion) in aggregate from Haleon from an offering and a share buyback. Goldman Sachs International said Tuesday that the pharmaceutical company ...

CVS Health's stock remains significantly undervalued by most metrics, even if management are struggling to unlock value.

Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...

Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) ...

Goldman Sachs, JP Morgan, Morgan Stanley and UBS are global coordinators on the trade, with Barclays, Bank of America, BNP ...

(Reuters) - Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon, a ...